← Back to Search

Non-pharmacological Therapy

TENS device for Kidney Stones

N/A
Recruiting
Led By Simon Conti, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult patients undergoing standard of care ureteroscopy and laser lithotripsy for urinary stone disease
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-10 days
Awards & highlights

Study Summary

This trialwill explore using Transcutaneous Neurostimulation (TENS) to reduce post-op pain & nausea from ureteral stent, & reduce narcotic use.

Eligible Conditions
  • Kidney Stones

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are an adult patient who will be receiving standard treatment for urinary stone disease, which involves ureteroscopy and laser lithotripsy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-10 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-10 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain on 11-point Visual Analog Score scale for each day until Ureteral Stent removed

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TENS deviceExperimental Treatment1 Intervention
Participants will use the TENS device until the ureteral stent is removed
Group II: Standard careActive Control1 Intervention
Participants will follow standard care until the ureteral stent is removed
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TENS
2011
Completed Phase 2
~2040

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,948 Total Patients Enrolled
Simon Conti, MDPrincipal InvestigatorStanford University

Media Library

TENS (Non-pharmacological Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05153629 — N/A
Kidney Stones Research Study Groups: Standard care, TENS device
Kidney Stones Clinical Trial 2023: TENS Highlights & Side Effects. Trial Name: NCT05153629 — N/A
TENS (Non-pharmacological Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05153629 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility criteria for partaking in this medical research?

"To qualify for this trial, a potential participant must have kidney stones and be between the ages of 18-70. There is room to accept 60 participants in total."

Answered by AI

How much participation has this investigation attracted?

"Affirmative. Clinicaltrials.gov's data verifies that this trial, first posted on January 10th 2021, is actively seeking participants. Sixty individuals need to be recruited from one medical site."

Answered by AI

Does this experimental program accept participants over 25 years of age?

"The study requires that participants must be 18 years of age or older, but not beyond 70."

Answered by AI

Is this research endeavor presently recruiting participants?

"Clinicaltrials.gov has reported that this clinical trial is currently enrolling and was originally published on the 10th of January 2021, with its most recent update being uploaded on the 31st of October 2022."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy
Simon Conti 2021. "Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05153629.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top